Camurus AB

Camurus AB

Health CarePharmaceuticals & Biotechnology
  • Price (SEK)85.20
  • Today's Change-1.00 / -1.16%
  • Shares traded78.07k
  • 1 Year change-19.08%
  • Beta1.2531
Data delayed at least 15 minutes, as of Sep 20 2019 17:00 BST.
More ▼

Events & Activity

  • CAMX:STO trading volume exceeds daily average by +25.69%
  • CAMX:STO price moved over -1.02% to 87.00
  • CAMX:STO price rises above 15-day moving average to 88.50 at 10:02 BST
  • CAMX:STO price falls below 15-day moving average to 88.30 at 17:33 BST

Key statistics

On Friday, Camurus AB (CAMX:STO) closed at 85.20, -23.47% below its 52-week high of 111.33, set on Sep 21, 2018.
52-week range
54.66Jan 08 2019111.33Sep 21 2018
Markit short selling activity
Previous close86.20
Average volume53.61k
Shares outstanding47.98m
Free float20.96m
P/E (TTM)--
Market cap4.09bn SEK
EPS (TTM)-6.45
Data delayed at least 15 minutes, as of Sep 20 2019 17:00 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.